| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 55,971 | 57,381 | 57,634 | 57,617 | | Cost of Revenue | 24,058 | 45,616 | 37,819 | 43,335 | | | Gross Profit | 31,913 | 11,765 | 19,815 | 14,282 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,122 | (1,586) | 8,361 | 3,251 | | Non Recurring | 148 |
-
| 16,315 |
-
| | Others | 5,245 | 5,316 | 5,028 | 4,775 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,398 | 8,035 | (9,889) | 6,256 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 8 | 13 | 143 | | Earnings Before Interest And Taxes | 8,403 | 8,043 | (9,876) | 6,399 | | Interest Expense | 1,635 | 1,973 | 1,843 | 1,876 | | Income Before Tax | 6,768 | 6,070 | (11,719) | 4,523 | | Income Tax Expense | 2,402 | 2,163 | 56 | 1,493 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,366 | 3,907 | (11,775) | 3,030 | | | Non-recurring Events | | Discontinued Operations | (980) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,386 | 3,907 | (11,775) | 3,030 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,386 | $3,907 | ($11,775) | $3,030 |
|
0.26% Nasdaq 0.00%
Income Statement
